Literature DB >> 17286904

[Serum IL-21 level in patients with primary Sjogren's syndrome and clinical significance of IL-21].

Shuang-long Yuan1, Li Jiang, Xiao-li Zhang, Shu-fan Li, Hong-mei Duan, Xiao-fei Wang.   

Abstract

AIM: To investigate the relation between the change of serum IL-21 level and other laboratory indexes by detecting serum IL-21 level from patients with primary Sjogren's syndrome (pSS) and explore the role of IL-21 in pSS.
METHODS: The level of serum IL-21 from 40 pSS patients diagnosed according to 2002 revised international classification criteria for pSS and 30 healthy persons were detected by enzyme-linked immunosorbent assay(ELISA) respectively. Meanwhile, FT3, FT4, TSH, TgAb, TPOAb were detected by Immunochemiluminescent technique. Double diffusion method, Westergren and automatic gel method detected ant-SSA and ant-SSB antibody, ESR and serum protein electrophoresis respectively. The relationship between serum IL-21 level and other clinical symptom of the patients was analyzed.
RESULTS: The level of serum IL-21 in patients with pSS (1051+/-335) ng/L was obviously higher than that in healthy control (466+/-90 ng/L), (P<0.05). The levels of serum IL-21 in the self-antibody positive group, parotid gland swelling pain group, rash group and incorporating hypothyroidism group were higher than those in their negative control groups, and there were significant differences(P<0.05). In addition, The level of serum IL-21 level in pSS patients showed positive correlation with gamma-globulin (r=0.719, P<0.05) and ESR level(r=0.745, P<0.05).
CONCLUSION: The evident increase of serum IL-21 level in pSS patients has positive correlation with the levels of gamma-globulin and ESR, which suggests that IL-21 may play a critical role in the pathogenesis of pSS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286904

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  5 in total

1.  Spontaneous autoimmune dacryoadenitis in aged CD25KO mice.

Authors:  Ehsan Rahimy; John D Pitcher; Solherny B Pangelinan; Wei Chen; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder; Cintia S De Paiva
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

2.  Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.

Authors:  Kwi Young Kang; Hyun-Ok Kim; Seung-Ki Kwok; Ji Hyeon Ju; Kyung-Su Park; Dong-Il Sun; Joo Yeon Jhun; Hye Jwa Oh; Sung-Hwan Park; Ho-Youn Kim
Journal:  Arthritis Res Ther       Date:  2011-10-26       Impact factor: 5.156

3.  IL-21 and Sjögren's syndrome.

Authors:  R Hal Scofield
Journal:  Arthritis Res Ther       Date:  2011-12-19       Impact factor: 5.156

4.  Polymorphisms of interleukin-21 and interleukin-21-receptor genes confer risk for autoimmune thyroid diseases.

Authors:  Jian Zhang; Wan Xia Xiao; Yuan Feng Zhu; Fatuma Said Muhali; Ling Xiao; Wen Juan Jiang; Xiao Hong Shi; Lian Hua Zhou; Jin An Zhang
Journal:  BMC Endocr Disord       Date:  2013-07-29       Impact factor: 2.763

Review 5.  Unique Phenotypes and Functions of Follicular Helper T Cells and Regulatory T Cells in Sjögren's Syndrome.

Authors:  Masako Saito; Kunihiro Otsuka; Aya Ushio; Akiko Yamada; Rieko Arakaki; Yasusei Kudo; Naozumi Ishimaru
Journal:  Curr Rheumatol Rev       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.